- Home
- HOWL vs WIMI Comparison
HOWL vs WIMI Comparison
Compare HOWL & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- WIMI
- Stock Information
- Founded
- HOWL 2017
- WIMI 2015
- Country
- HOWL United States
- WIMI China
- Employees
- HOWL N/A
- WIMI N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- WIMI Computer Software: Prepackaged Software
- Sector
- HOWL Health Care
- WIMI Technology
- Exchange
- HOWL Nasdaq
- WIMI Nasdaq
- Market Cap
- HOWL 47.1M
- WIMI 38.3M
- IPO Year
- HOWL 2021
- WIMI 2020
- Fundamental
- Price
- HOWL $1.33
- WIMI $3.97
- Analyst Decision
- HOWL Strong Buy
- WIMI
- Analyst Count
- HOWL 5
- WIMI 0
- Target Price
- HOWL $7.20
- WIMI N/A
- AVG Volume (30 Days)
- HOWL 135.8K
- WIMI 233.8K
- Earning Date
- HOWL 11-06-2025
- WIMI 01-01-0001
- Dividend Yield
- HOWL N/A
- WIMI N/A
- EPS Growth
- HOWL N/A
- WIMI N/A
- EPS
- HOWL N/A
- WIMI 1.00
- Revenue
- HOWL N/A
- WIMI $74,245,408.00
- Revenue This Year
- HOWL N/A
- WIMI N/A
- Revenue Next Year
- HOWL N/A
- WIMI N/A
- P/E Ratio
- HOWL N/A
- WIMI $3.88
- Revenue Growth
- HOWL N/A
- WIMI N/A
- 52 Week Low
- HOWL $0.60
- WIMI $2.24
- 52 Week High
- HOWL $4.18
- WIMI $29.20
- Technical
- Relative Strength Index (RSI)
- HOWL 52.75
- WIMI 55.18
- Support Level
- HOWL $1.29
- WIMI $3.58
- Resistance Level
- HOWL $1.40
- WIMI $4.07
- Average True Range (ATR)
- HOWL 0.07
- WIMI 0.22
- MACD
- HOWL 0.00
- WIMI -0.01
- Stochastic Oscillator
- HOWL 61.90
- WIMI 73.68
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.